Clinical Trials Browser

Phase 2 × Glioblastoma × Immune Checkpoint Inhibitors × Clear all

NCT04225039 2025-08-15

Anti-GITR/Anti-PD1/Stereotactic Radiosurgery, in Recurrent Glioblastoma

Phase 2 Active not recruiting

39 enrolled 10 charts

Glioblastoma